|
ILF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.896400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.130000E-02 |
| Normal-vs-Stage2 |
4.987800E-01 |
| Normal-vs-Stage3 |
2.157000E-01 |
| Normal-vs-Stage4 |
3.059600E-01 |
| Stage1-vs-Stage2 |
9.131800E-01 |
| Stage1-vs-Stage3 |
8.980800E-01 |
| Stage1-vs-Stage4 |
9.390600E-01 |
| Stage2-vs-Stage3 |
8.692000E-01 |
| Stage2-vs-Stage4 |
9.926600E-01 |
| Stage3-vs-Stage4 |
8.751400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.275800E-03 |
| Normal-vs-AfricanAmerican |
2.332000E-01 |
| Normal-vs-Asian |
4.366200E-01 |
| Caucasian-vs-AfricanAmerican |
3.685800E-01 |
| Caucasian-vs-Asian |
9.662200E-01 |
| AfricanAmerican-vs-Asian |
7.210400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.833700E-02 |
| Normal-vs-Female |
6.160100E-04 |
| Male-vs-Female |
1.330240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.478400E-02 |
| Normal-vs-Extreme_Weight |
3.305800E-01 |
| Normal-vs-Obese |
1.137770E-02 |
| Normal-vs-Extreme_Obese |
5.806000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.631400E-01 |
| Normal_Weight-vs-Obese |
6.916800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.364210E-01 |
| Extreme_Weight-vs-Obese |
1.014420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.364600E-01 |
| Obese-vs-Extreme_Obese |
2.220200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.702800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.598150E-03 |
| Normal-vs-Age(61-80Yrs) |
1.336420E-01 |
| Normal-vs-Age(81-100Yrs) |
1.585750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.048170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.221700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.436400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.325500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.778100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.912100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.160700E-04 |
| Normal-VS-Type2 PRCC |
1.173180E-01 |
| Normal-VS-KIRP CIMP |
4.221800E-02 |
| Normal-VS-Unclassified PRCC |
5.407800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.47549999949004E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.898000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.472200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.360600E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.260780E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.237200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.874800E-01 |
| Normal-vs-N1 |
2.134100E-02 |
| Normal-vs-N2 |
1.174600E-01 |
| N0-vs-N1 |
3.395600E-02 |
| N0-vs-N2 |
2.858000E-01 |
| N1-vs-N2 |
8.379000E-01 |
|
|
